Pharmaceutical Cocrystals of Nicorandil with Enhanced Chemical Stability and Sustained Release
- 7 October 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 20 (10), 6995-7005
- https://doi.org/10.1021/acs.cgd.0c01043
Abstract
No abstract availableFunding Information
- Natural Science Foundation of Shanghai (18ZR1447900)
- Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences
- Sanofi
- Youth Innovation Promotion Association of the Chinese Academy of Sciences (2016257)
- National Natural Science Foundation of China (21576080, 21776073)
- Chinese Academy of Sciences
This publication has 38 references indexed in Scilit:
- In vitro and in vivo evaluation of hydrophilic and hydrophobic polymers-based nicorandil-loaded peroral tablet compared with its once-daily commercial sustained-release tabletDrug Development and Industrial Pharmacy, 2010
- Understanding the relationship between crystal structure, plasticity and compaction behaviour of theophylline, methyl gallate, and their 1 : 1 co-crystalCrystEngComm, 2010
- Hybrid insulin cocrystals for controlled release deliveryNature Biotechnology, 2002
- Formulation Optimization and Stability Study of Transdermal Therapeutic System of NicorandilPharmaceutical Development and Technology, 2002
- Dose-related haemodynamic effects and pharmacokinetics of oral nicorandil in patients evaluated for chest painInternational Journal of Cardiology, 1994
- NicorandilDrugs, 1992
- Pharmacokinetics of nicorandilThe American Journal of Cardiology, 1989
- Nicorandil as a hybrid between nitrates and potassium channel activatorsThe American Journal of Cardiology, 1989
- Structure of N-[2-(nitrooxy)ethyl]nicotinamide (SG 75)Acta Crystallographica Section C Crystal Structure Communications, 1987
- The stability of nicorandil in aqueous solution. I. Kinetics and mechanism of decomposition of N-(2-hydroxyethyl)nicotinamide nitrate (ester) in aqueous solution.CHEMICAL & PHARMACEUTICAL BULLETIN, 1984